SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-11-009007
Filing Date
2011-11-03
Accepted
2011-11-03 17:16:53
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2206080z10-q.htm 10-Q 856705
2 EX-31.1 a2206080zex-31_1.htm EX-31.1 7910
3 EX-31.2 a2206080zex-31_2.htm EX-31.2 7925
4 EX-32.1 a2206080zex-32_1.htm EX-32.1 4774
  Complete submission text file 0001047469-11-009007.txt   9108965

Data Files

Seq Description Document Type Size
5 EX-101.INS vrtx-20110930.xml EX-101.INS 1076624
6 EX-101.SCH vrtx-20110930.xsd EX-101.SCH 130659
7 EX-101.CAL vrtx-20110930_cal.xml EX-101.CAL 129871
8 EX-101.LAB vrtx-20110930_lab.xml EX-101.LAB 1762877
9 EX-101.PRE vrtx-20110930_pre.xml EX-101.PRE 753409
10 EX-101.DEF vrtx-20110930_def.xml EX-101.DEF 483572
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 111178572
SIC: 2834 Pharmaceutical Preparations